Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Nov;18(11):e015902.
doi: 10.1161/CIRCINTERVENTIONS.125.015902. Epub 2025 Oct 3.

Complete Revascularization in Older Patients With Myocardial Infarction With or Without Complex Nonculprit Lesions

Affiliations
Free article
Randomized Controlled Trial

Complete Revascularization in Older Patients With Myocardial Infarction With or Without Complex Nonculprit Lesions

Alberto Sarti et al. Circ Cardiovasc Interv. 2025 Nov.
Free article

Abstract

Background: The FIRE trial (Functional Assessment in Elderly Myocardial Infarction Patients With Multivessel Disease) showed the superiority of complete revascularization in older patients with myocardial infarction (MI) and multivessel disease. Whether this result applies equally to patients at higher risk of ischemic events due to nonculprit lesion complexity is unclear.

Methods: Overall, 1445 patients were randomized to culprit-only or complete revascularization. In this prespecified analysis, patients were divided into those with or without at least 1 complex nonculprit lesion. A nonculprit lesion was defined as complex if it met any of the following criteria: angiographic heavy calcification, ostial lesion, true bifurcation lesion involving side-branches >2.5 mm, in-stent restenosis, or long-lesions (estimated stent length >28 mm). The primary outcome comprised a composite of death, MI, stroke, or revascularization at 3 years. The key secondary outcome was a composite of cardiovascular death or MI. The safety outcome included a composite of contrast-associated acute kidney injury, stroke, and Bleeding Academic Research Consortium 3 to 5.

Results: Overall, 641 patients (44%, complex subgroup) had at least 1 complex nonculprit lesion, whereas 804 patients (56%, noncomplex subgroup) did not. After adjustment for potential confounders, patients in the complex subgroup were at higher risk of 3-year cardiovascular death or MI (hazard risk [HR], 1.32 [95% CI, 1.01-1.74]), MI (HR, 2.33 [95% CI, 1.44-3.78]) and ischemia-driven coronary revascularization (HR, 2.28 [95% CI, 1.46-3.56]). Complete revascularization reduced the primary outcome in both the complex (HR, 0.75 [95% CI, 0.56-0.99]) and noncomplex (HR, 0.71 [95% CI, 0.53-0.95]) subgroups, with no significant interaction (P for interaction=0.625). Similarly, no evidence of heterogeneity related to nonculprit lesion complexity was observed for either key secondary or safety end points.

Conclusions: In older patients with MI and multivessel disease, physiology-guided complete revascularization reduced ischemic events, regardless of the complexity of nonculprit lesions.

Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03772743.

Keywords: acute kidney injury; aged; myocardial infarction; percutaneous coronary intervention; stents.

PubMed Disclaimer

Conflict of interest statement

Dr Campo received research grants and personal fees from Abbott Vascular, GADA, Menarini, Amgen, Daiichi Sankyo, and Sanofi, outside the submitted work. Dr Biscaglia received personal fees from Abbott Vascular and Siemens Healthcare, outside the submitted work. Dr Moreno declares speaker/consulting fees from Abbott Vascular, AMGEN, AstraZeneca, Biosensors, Biotronik, Boston Scientific, Daiichi Sankyo, Edwards, Medtronic, and Philips, outside the submitted work. The other authors report no conflicts.

Publication types

MeSH terms

Associated data

LinkOut - more resources